Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME …

A Bex, P Mulders, M Jewett, J Wagstaff… - JAMA …, 2019 - jamanetwork.com
Importance In clinical practice, patients with primary metastatic renal cell carcinoma (mRCC)
have been offered cytoreductive nephrectomy (CN) followed by targeted therapy, but the …
被引用次数：454 相关文章
[PDF] ulb.ac.be

[PDF][PDF] Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib The …

A Bex, P Mulders, M Jewett, J Wagstaff, JV van Thienen… - JAMA, 2019 - dipot.ulb.ac.be
OBJECTIVE To examine whether a period of sunitinib therapy before CN improves outcome
compared with immediate CN followed by sunitinib. DESIGN, SETTING, AND …
[HTML] nih.gov

[HTML][HTML] Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The …

A Bex, P Mulders, M Jewett, J Wagstaff… - JAMA …, 2019 - ncbi.nlm.nih.gov
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With
Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib - PMC Back to Top Skip to …
[PDF] uclouvain.be

[PDF][PDF] Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib The …

A Bex, P Mulders, M Jewett, J Wagstaff, JV van Thienen… - 2018 - dial.uclouvain.be
OBJECTIVE To examine whether a period of sunitinib therapy before CN improves outcome
compared with immediate CN followed by sunitinib. DESIGN, SETTING, AND …

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME …

A Bex, P Mulders, M Jewett, J Wagstaff… - JAMA …, 2019 - europepmc.org
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With
Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized …

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME …

A Bex, P Mulders, M Jewett, J Wagstaff… - JAMA …, 2019 - research.rug.nl
Importance: In clinical practice, patients with primary metastatic renal cell carcinoma
(mRCC) have been offered cytoreductive nephrectomy (CN) followed by targeted therapy …
[HTML] swan.ac.uk

[HTML][HTML] Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

A Bex, P Mulders, M Jewett, J Wagstaff… - JAMA …, 2019 - cronfa.swan.ac.uk
This was a randomised phase II trial of immediate versus deferred nephrectomy in patients
who were diagnosed with metastatic renal cancer with the primary cancer still in situ …

[引用][C] Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

A Bex, P Mulders, M Jewett, J Wagstaff… - JAMA Oncology, 2019 - cir.nii.ac.jp
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With
Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib | CiNii Research CiNii 国立 …

[引用][C] Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The …

A Bex, P Mulders, MAS Jewett, J Wagstaff… - JAMA …, 2019 - difusion.ulb.ac.be

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME …

A Bex, P Mulders, M Jewett, J Wagstaff… - JAMA …, 2019 - pubmed.ncbi.nlm.nih.gov
Importance In clinical practice, patients with primary metastatic renal cell carcinoma (mRCC)
have been offered cytoreductive nephrectomy (CN) followed by targeted therapy, but the …